Your browser doesn't support javascript.
loading
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation.
Martin, Natasha K; Vickerman, Peter; Dore, Gregory J; Grebely, Jason; Miners, Alec; Cairns, John; Foster, Graham R; Hutchinson, Sharon J; Goldberg, David J; Martin, Thomas C S; Ramsay, Mary; Hickman, Matthew.
Afiliação
  • Martin NK; Division of Global Public Health, University of California San Diego, San Diego, USA; School of Social and Community Medicine, University of Bristol, UK. Electronic address: Natasha-martin@ucsd.edu.
  • Vickerman P; School of Social and Community Medicine, University of Bristol, UK.
  • Dore GJ; Kirby Institute, UNSW Australia, Sydney, Australia.
  • Grebely J; Kirby Institute, UNSW Australia, Sydney, Australia.
  • Miners A; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK.
  • Cairns J; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK.
  • Foster GR; Queen Mary's University of London, UK.
  • Hutchinson SJ; Glasgow Caledonian University, UK; Health Protection Scotland, UK.
  • Goldberg DJ; Glasgow Caledonian University, UK; Health Protection Scotland, UK.
  • Martin TCS; Guy's and St Thomas's NHS Foundation Trust, London, UK.
  • Ramsay M; Public Health England, UK.
  • Hickman M; School of Social and Community Medicine, University of Bristol, UK.
J Hepatol ; 65(1): 17-25, 2016 07.
Article em En | MEDLINE | ID: mdl-26867489

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article